/ Everest Organics Gain After USFDA Inspection ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Tuesday, 6 June 2017

Everest Organics was locked in its upper circuit of Rs 108.15 per share higher by 5% intraday on Tuesday after a successful check of its facility by the US drug regulator.

However, the stock got unlocked from its upper circuit in the afternoon hours and was trading flat at Rs 103 per share as of 1415 hours.

The US Food and Drug Administration (FDA) had inspected its manufacturing facility at Aroor village between February 27 and March 3, 2017 and the same has been approved.

Everest Organics Limited is an innovative research-driven, global pharmaceutical company that develops, manufactures and markets a broad range of APls / bulks drugs intermediates.

Everest Organics Limited globally exports more than 20 countries.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔